These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 10477718)

  • 1. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
    Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
    Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
    Andjelkovic AV; Pachter JS
    J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
    Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
    J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
    Blanpain C; Lee B; Tackoen M; Puffer B; Boom A; Libert F; Sharron M; Wittamer V; Vassart G; Doms RW; Parmentier M
    Blood; 2000 Sep; 96(5):1638-45. PubMed ID: 10961858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
    Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
    Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
    Lehner T; Wang Y; Cranage M; Tao L; Mitchell E; Bravery C; Doyle C; Pratt K; Hall G; Dennis M; Villinger L; Bergmeier L
    Immunology; 2000 Apr; 99(4):569-77. PubMed ID: 10792505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
    Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
    Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
    Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
    Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
    J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB; Glushakova S; Grivel JC; Murphy PM
    J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages.
    Tomkowicz B; Lee C; Ravyn V; Cheung R; Ptasznik A; Collman RG
    Blood; 2006 Aug; 108(4):1145-50. PubMed ID: 16621960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.